OptimizeRx Corp. Files 8-K on Financials
Ticker: OPRX · Form: 8-K · Filed: May 14, 2024 · CIK: 1448431
| Field | Detail |
|---|---|
| Company | Optimizerx CORP (OPRX) |
| Form Type | 8-K |
| Filed Date | May 14, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, sec-filing
TL;DR
OptimizeRx filed an 8-K updating investors on their financial condition.
AI Summary
OptimizeRx Corp. filed an 8-K on May 14, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, but does not contain specific financial figures or operational details within the provided text.
Why It Matters
This filing indicates OptimizeRx Corp. is providing an update on its financial performance and condition to the SEC, which is important for investors to monitor the company's health.
Risk Assessment
Risk Level: low — This is a routine SEC filing reporting on financial condition and results of operations, with no immediate negative or positive indicators in the provided text.
Key Players & Entities
- OptimizeRx Corp. (company) — Registrant
- 260 Charles Street, Suite 302, Waltham, MA 02453 (location) — Principal executive offices address
- May 14, 2024 (date) — Date of earliest event reported
FAQ
What specific financial results are being reported by OptimizeRx Corp. in this 8-K filing?
The provided text of the 8-K filing indicates it pertains to 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits,' but does not detail the specific financial figures or results within this excerpt.
When was this 8-K filing submitted to the SEC?
The filing was submitted on May 14, 2024, as indicated by the 'Date of Report (Date of Earliest Event Reported)' and 'FILED AS OF DATE'.
What is the state of incorporation for OptimizeRx Corporation?
OptimizeRx Corporation is incorporated in Nevada, as stated in the filing.
What is the IRS Employer Identification Number for OptimizeRx Corp.?
The IRS Employer Identification Number for OptimizeRx Corp. is 26-1265381.
What is the primary business address of OptimizeRx Corp.?
The primary business address for OptimizeRx Corp. is 260 Charles Street, Suite 302, Waltham, MA 02453.
Filing Stats: 514 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2024-05-14 16:10:31
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 Par Value OPRX The Nasdaq Capital M
Filing Documents
- ea0206046-8k_optimize.htm (8-K) — 24KB
- ea020604601ex99-1_optimize.htm (EX-99.1) — 97KB
- ex99-1_001.jpg (GRAPHIC) — 4KB
- 0001213900-24-042937.txt ( ) — 309KB
- oprx-20240514.xsd (EX-101.SCH) — 3KB
- oprx-20240514_lab.xml (EX-101.LAB) — 33KB
- oprx-20240514_pre.xml (EX-101.PRE) — 22KB
- ea0206046-8k_optimize_htm.xml (XML) — 4KB
02 Results of Operations and Financial
Item 2.02 Results of Operations and Financial Condition. On May 14, 2024, OptimizeRx Corporation issued a press release announcing its financial results for the first quarter ended March 31, 2024. A copy of the press release is furnished with this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference. The information in this Item 2.02 and Exhibit 99.1 attached hereto are furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. Exhibit Number Description 99.1 Press Release, dated May 14, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. OPTIMIZERX CORPORATION Date: May 14, 2024 By: /s/ Edward Stelmakh Name: Edward Stelmakh Title: Chief Financial Officer 2